- Filed
- Aug 12, 2022 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2022 · Aug 8, 2022 | 90.12M sh |
| Short Term Investments | Q2 2022 · Jun 30, 2022 | $121.32M |
| Short Term Investments | Q2 2022 · Dec 31, 2021 | $0 |
| Cash And Equivalents | Q2 2022 · Jun 30, 2022 | $78.11M |
| Cash And Equivalents | Q2 2022 · Dec 31, 2021 | $238.82M |
| Current Liabilities | Q2 2022 · Jun 30, 2022 | $18.8M |
| Current Liabilities | Q2 2022 · Dec 31, 2021 | $7.98M |
| Total Liabilities | Q2 2022 · Jun 30, 2022 | $18.86M |
| Total Liabilities | Q2 2022 · Dec 31, 2021 | $8.05M |
| Current Assets | Q2 2022 · Jun 30, 2022 | $204.91M |
| Current Assets | Q2 2022 · Dec 31, 2021 | $243.85M |
| Total Assets | Q2 2022 · Jun 30, 2022 | $234.24M |
| Total Assets | Q2 2022 · Dec 31, 2021 | $263.26M |
| Shares Diluted | Q2 2022 · Jun 30, 2021 | 57.58M sh |
| Shares Diluted | Q2 2022 · Jun 30, 2021 | 57.12M sh |
| Dividends Paid | Q2 2022 · Jun 30, 2021 | $0 |
| Capex restated | Q2 2022 · Jun 30, 2021 | $3.24M |
| Operating Cash Flow restated | Q2 2022 · Jun 30, 2021 | −$19.44M |
| Eps Diluted | Q2 2022 · Jun 30, 2021 | −$0.15 |
| Eps Diluted | Q2 2022 · Jun 30, 2021 | −$0.26 |
| Eps Basic | Q2 2022 · Jun 30, 2021 | −$0.15 |
| Eps Basic | Q2 2022 · Jun 30, 2021 | −$0.26 |
| Sga Expense | Q2 2022 · Jun 30, 2021 | $1.95M |
| Sga Expense | Q2 2022 · Jun 30, 2021 | $3.41M |
| Rd Expense | Q2 2022 · Jun 30, 2021 | $6.7M |
| Rd Expense | Q2 2022 · Jun 30, 2021 | $10.97M |
| Net Income | Q2 2022 · Jun 30, 2021 | −$8.8M |
| Net Income | Q2 2022 · Jun 30, 2021 | −$14.59M |
| Net Income | Q2 2022 · Mar 31, 2021 | −$5.78M |
| Operating Income | Q2 2022 · Jun 30, 2021 | −$8.65M |
| Operating Income | Q2 2022 · Jun 30, 2021 | −$14.38M |